Pfizer to shutter Boulder R&D operations
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) will shut down its research and development facility in Boulder in the coming months.
Source: dailycamera.com
📰 Array Biopharma News
Page 2 - Array Biopharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Array Biopharma. Real-time updates on events, politics, business and more.
Record funding propels Denver-Boulder's life sciences market
Denver-Boulder is rapidly becoming a life sciences hub thanks to a surge in funding, research collaborations and lab space.
Source: cnbc.com
Record levels of funding propel Denver-Boulder to the top of the life sciences market
Denver-Boulder is rapidly becoming a life sciences hub thanks to a surge in funding, research collaborations and lab space.
Source: nbcnewyork.com
Adagrasib/Cetuximab Combo Has Activity in KRAS G12C+ Locally Advanced or mCRC
Adagrasib plus cetuximab elicited a 34% objective response rate in patients with previously treated KRAS G12C-mutant advanced colorectal cancer.
Source: onclive.com
Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
Source: marketscreener.com
Up to 10 Years of Follow-Up Uphold Survival Benefit With Adjuvant Dabrafenib/Trametinib in Stage III Melanoma
The COMBI-AD dataset is the longest follow-up to date of adjuvant treatment for patients with stage III melanoma.
Western Australia New South Wales Innovent Biologics Pierre Fabre Boehringer Ingelheim Bristol Myers Squibb
Source: onclive.com
Pfizer Gets FDA OK of Drug Combination in Non-Small Cell Lung Cancer
By Colin Kellaher Pfizer has won expanded approval from the U.S. Food and Drug Administration of the combination of its Braftovi and Mektovi drugs for...
Source: marketwatch.com
FDA OKs Drug Combo in BRAF V600E-Mutated Metastatic NSCLC
The single-arm approval study reported an objective response rate of 75% among treatment-naive patients.
New York United States Memorial Sloan Kettering Cancer Center Gregory Riely Foundationone Cdx Drug Administration
Source: medscape.com
Pfizer to cut R&D jobs in Boulder
Pfizer Inc. is laying off an unspecified number of workers in its Boulder research and development operation.
United States Array Biopharma Inc Tritower Financial Group Colorado Department Of Labor Invesco Ltd Pfizer Inc
Source: dailycamera.com
Evolve and Pfizer cutting workers in Denver and Boulder
Denver-based Evolve is letting go of another 175 workers just four months after it dismissed 164 workers in response to a big drop-off in the vacation home rental market.
United States Pam Jefferson Brian Egan Gray Christmas Inc Colorado Department Of Labor Denver Based Evolve
Source: denverpost.com